Radhiyatam Mardhiyah

Radhiyatam Mardhiyah

Auto-generated profile, based on publicly available information

Radhiyatam Mardhiyah

University of Indonesia: Universitas Indonesia

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 September 2026 in Research Square
Verified
Preprint
Open access
PDF file
RMRadhiyatam Mardhiyah
Radhiyatam Mardhiyah
AAAnna Ariane
Anna Ariane
SUSumariyono
Sumariyono
KSKanadi Sumapraja
Kanadi Sumapraja
RSRobert Sinto
Robert Sinto
MAMutiara Rahmah Amari
Mutiara Rahmah Amari
Background . Systemic lupus erythematosus (SLE) predominantly affects women of reproductive age and may be accompanied by menstrual and reproductive dysfunction. Menstrual disturbances may raise concerns regarding premature ovarian insufficiency (POI), a condition characterized by menstrual disturbances accompanied by biochemical evidence of ovarian insufficiency, typically reflected by elevated serum follicle-stimulating hormone (FSH) levels. However, menstrual abnormalities do not necessarily indicate ovarian insufficiency. Objective . To evaluate menstrual disturbances and serum follicle-stimulating hormone (FSH) findings among reproductive-aged women with SLE and to explore their associations with SLE disease activity and cyclophosphamide exposure. Methods . This cross-sectional study included 175 consecutively recruited women with SLE aged 18–39 years. Menstrual history was assessed by direct interview to identify oligomenorrhea or amenorrhea. Serum FSH was measured in participants with menstrual disturbances. Disease activity was evaluated using high disease activity status (HDAS), defined as SLEDAI-2K ≥ 10, and cyclophosphamide exposure was obtained from medical records. Associations with menstrual disturbances were assessed using bivariate analyses and an exploratory multivariable logistic regression model. Results . Thirty of 175 participants (17.1%) reported oligomenorrhea or amenorrhea. Among these 30 participants, median serum FSH was 5.24 IU/L (range 1.90-20.71 IU/L), and none had an FSH concentration > 25 IU/L. HDAS was more frequent among participants with menstrual disturbances than among those without menstrual disturbances (50.0% vs 26.9%; p = 0.013). In exploratory multivariable analysis adjusted for age and prior cyclophosphamide exposure, HDAS remained associated with menstrual disturbances (adjusted OR 2.75, 95% CI 1.18–6.38; p = 0.019). Prior cyclophosphamide exposure was not significantly associated with menstrual disturbances (13.3% vs 9.7%; p = 0.517). Conclusion . Menstrual disturbances were observed in approximately one-sixth of reproductive-aged women with SLE and were associated with high disease activity. However, elevated serum FSH concentrations suggestive of ovarian insufficiency were not observed among symptomatic participants. The association between cyclophosphamide exposure and menstrual dysfunction remains inconclusive because few participants had received cyclophosphamide and cumulative doses were predominantly low. Longitudinal studies incorporating serial hormonal assessment are needed to better characterize reproductive dysfunction in women with SLE.